3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Polycythemia Vera
2
Myeloproliferative Disorders
2
Lung Neoplasms
2
Tuberous Sclerosis
1
Smoking
1
Renal Insufficiency, Chronic
1
Pancreatitis, Chronic
1
Pancreatitis
1
Pancreatic Cyst
1
Non-alcoholic Fatty Liver Disease
1
Neoplasms
1
Multiple Sclerosis
1
Lymphangioleiomyomatosis
1
Liver Cirrhosis, Biliary
1
Lip Neoplasms
1
Irritable Bowel Syndrome
1
Inflammatory Bowel Diseases
1
Hepatitis
1
Head and Neck Neoplasms
1
Genetic Predisposition to Disease
1
Gastritis
1
Fibrosis
1
Exocrine Pancreatic Insufficiency
1
Endocrine Gland Neoplasms
1
Dyslipidemias
1
Diabetes Mellitus
1
Cystic Fibrosis
1
Crohn Disease
1
Chronic Pain
1
Chronic Disease
1
Interventions
pembrolizumab
14
Nivolumab
11
Ipilimumab
10
cabozantinib
6
Axitinib
6
belzutifan
5
Radiosurgery
5
atezolizumab
4
Sunitinib
4
palbociclib
3
lenvatinib
3
Surveys and Questionnaires
3
Radiotherapy
3
Pluvicto
3
Everolimus
3
Blood Specimen Collection
3
Biopsy
3
zimberelimab
2
pazopanib
2
cemiplimab
2
Therapeutics
2
Methods
2
Magnetic Resonance Spectroscopy
2
Irinotecan
2
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
2
trebananib
1
toripalimab
1
tocilizumab
1
temsirolimus
1
spartalizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
Phlebotomy
×
1 year
×
Clear all
No trials found.